MAPK3 and breast cancer: Moreover, ERK1/2 inhibitor indeed affects some aspects of cellular functions, so clinically, it might be helpful to define optimal targeted delivery of this inhibitor to develop more effective therapeutics for ERK1/2 signal-activated BC patients.